关注
Sanjay Lalwani
Sanjay Lalwani
Professor, Department of Pediatircs, Bharati Vidyapeeth (DTU) Medical College, Pune
在 bharatividyapeeth.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prevalence and determinants of undernutrition among under-five children residing in urban slums and rural area, Maharashtra, India: a community-based cross-sectional study
S Murarkar, J Gothankar, P Doke, P Pore, S Lalwani, G Dhumale, ...
BMC public health 20, 1-9, 2020
1242020
Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season
S Shrivastava, D Tiraki, A Diwan, SK Lalwani, M Modak, AC Mishra, ...
PLoS One 13 (2), e0192672, 2018
862018
Reported incidence and risk factors of childhood pneumonia in India: a community-based cross-sectional study
J Gothankar, P Doke, G Dhumale, P Pore, S Lalwani, S Quraishi, ...
BMC public health 18, 1-11, 2018
752018
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial
RW Sutter, S Bahl, JM Deshpande, H Verma, M Ahmad, P Venugopal, ...
The Lancet 386 (10011), 2413-2421, 2015
662015
Invasive pneumococcal disease in children aged younger than 5 years in India: a surveillance study
A Manoharan, V Manchanda, S Balasubramanian, S Lalwani, M Modak, ...
The Lancet Infectious Diseases 17 (3), 305-312, 2017
652017
Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons
C Claeys, K Zaman, G Dbaibo, P Li, A Izu, P Kosalaraksa, L Rivera, ...
The Lancet Child & Adolescent Health 2 (5), 338-349, 2018
632018
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine: subgroup analysis of participants from Asian countries
SM Garland, P Pitisuttithum, HYS Ngan, CH Cho, CY Lee, CA Chen, ...
The Journal of infectious diseases 218 (1), 95-108, 2018
532018
Epidemiological and clinical characteristics of COVID-19 in Indian children in the initial phase of the pandemic
B Sarangi, VS Reddy, JS Oswal, N Malshe, A Patil, M Chakraborty, ...
Indian pediatrics 57, 914-917, 2020
492020
Management of diabetic ketoacidosis in PICU
RR Jahagirdar, VV Khadilkar, AV Khadilkar, SK Lalwani
The Indian Journal of Pediatrics 74, 551-554, 2007
402007
Prevalence of the acute respiratory infections and associated factors in the rural areas and urban slum areas of western Maharashtra, India: a community-based cross-sectional study
S Murarkar, J Gothankar, P Doke, G Dhumale, PD Pore, S Lalwani, ...
Frontiers in public health 9, 723807, 2021
362021
Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+ Hib) vaccine in comparison with a foreign competitor following primary and …
HJ Sharma, S Yadav, SK Lalwani, SV Kapre, SS Jadhav, A Chakravarty, ...
Human vaccines 7 (4), 451-457, 2011
342011
Altered breast milk components in preeclampsia; An in-vitro proton NMR spectroscopy study
K Dangat, D Upadhyay, A Kilari, U Sharma, N Kemse, S Mehendale, ...
Clinica Chimica Acta 463, 75-83, 2016
322016
Antibody (IgA, IgG, and IgG subtype) responses to SARS-CoV-2 in severe and nonsevere COVID-19 patients
HP Patil, PS Rane, S Shrivastava, S Palkar, S Lalwani, AC Mishra, ...
Viral Immunology 34 (3), 201-209, 2021
312021
Fournier's gangrene
SP Patankar, SK Lalwani
Indian pediatrics 41 (5), 511-511, 2004
312004
Differential oxidative stress levels in mothers with preeclampsia delivering male and female babies
S Roy, M Dhobale, K Dangat, S Mehendale, S Lalwani, S Joshi
The Journal of Maternal-Fetal & Neonatal Medicine 28 (16), 1973-1980, 2015
302015
Immunogenicity and safety of a liquid hexavalent vaccine in Indian infants
J Chhatwal, S Lalwani, E Vidor
Indian pediatrics 54, 15-20, 2017
282017
Preeclampsia alters milk neurotrophins and long chain polyunsaturated fatty acids
K Dangat, A Kilari, S Mehendale, S Lalwani, S Joshi
International Journal of Developmental Neuroscience 33, 115-121, 2014
272014
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in India
YK Amdekar, SK Lalwani, A Bavdekar, S Balasubramanian, J Chhatwal, ...
The Pediatric infectious disease journal 32 (5), 509-516, 2013
262013
A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants
H Sharma, S Yadav, S Lalwani, V Gupta, S Kapre, S Jadhav, ...
Vaccine 29 (13), 2359-2364, 2011
262011
Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III …
S Lalwani, S Chatterjee, S Balasubramanian, A Bavdekar, S Mehta, ...
BMJ open 5 (9), e007202, 2015
252015
系统目前无法执行此操作,请稍后再试。
文章 1–20